Customized Corneal Cross-Linking with Microneedle-Mediated Riboflavin Delivery for Keratoconus Treatment
- PMID: 39246198
- DOI: 10.1002/adma.202408136
Customized Corneal Cross-Linking with Microneedle-Mediated Riboflavin Delivery for Keratoconus Treatment
Abstract
In this study, a novel customized corneal cross-linking (CXL) treatment is explored that utilizes microneedles (MNs) for targeted riboflavin (RF) administration prior to the CXL procedure. Unlike the conventional "one-size-fits-all" approach, this protocol offers an option for more precise and efficacious treatment. To simulate a customized corneal crosslinking technique, four distinct microneedle (MN) molds designs, including circular, semi-circular, annular and butterfly shaped, are crafted for loading an optimized RF-hyaluronic acid solution and for the subsequent fabrication of MN arrays with varying morphologies. These MNs can gently puncture the corneal epithelium while preserving the integrity of the underlying stromal layer. Following the application of these microneedles, RF solution is replenished to enhance the RF content within the stroma through the punctures created by the MNs, resulting in exceptional customized corneal cross-linking effects that are comparable to the conventional epi-off CXL protocol. Additionally, it flattened the corneal curvature within the treated zone and facilitated rapid postoperative recovery of corneal tissue. These findings suggest that the integration of customized microneedle RF delivery with corneal crosslinking technology represents a potential novel treatment modality, holding promise for the tailored treatment of corneal pathologies, and offering a more precise and efficient alternative to traditional methods.
Keywords: customized corneal cross‐linking; microneedles; riboflavin; targeted administration.
© 2024 Wiley‐VCH GmbH.
References
-
- A. D. Bui, A. Truong, N. D. Pasricha, M. Indaram, Clin. Ophthalmol. 2023, 17, 2705.
-
- H. Kandel, J. Y. Chen, S. Sahebjada, E. W. Chong, S. Wiffen, S. L. Watson, Cornea 2023, 42, 1377.
-
- M. Song, T. Chen, A. Moktar, E. Chan, E. W. Chong, M. Daniell, S. Sahebjada, Children 2022, 9, 1973.
-
- A. M. Gănescu, Med. Pharm. Rep. 2022, 95, 385.
-
- K. S. Ceylanoglu, B. Aydin, M. C. Ozmen, Int. J. Ophthalmol. 2019, 12, 582.
MeSH terms
Substances
Grants and funding
- 23ZR1409500/Shanghai Science and Technology
- 23S11900200/Shanghai Science and Technology
- 23XD1420500/Shanghai Science and Technology
- 22S11900200/Shanghai Science and Technology
- 2021318/EYE & ENT Hospital of Fudan University High-level Talents Program
- SHDC2020CR1043B/Clinical Research Plan of SHDC
- yg2023-06/Medical Engineering fund of Fudan University
- yg2023-26/Medical Engineering fund of Fudan University
- 2020-015/Project of Shanghai Xuhui District Science and Technology
- SACA-CY22C03/Shanghai Anticancer Association EYAS PROJECT
- TP2022046/Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning
- 82271048/National Natural Science Foundation of China
- MR/S037829/1/MRC_/Medical Research Council/United Kingdom
LinkOut - more resources
Full Text Sources